Schistosoma japonicum-related hepatitis: potential contributor to hepatocellular carcinoma

QJM. 2024 Oct 1;117(10):737-738. doi: 10.1093/qjmed/hcae116.

S Kato^{1

2}, Y Shigematsu^{1

3}, R Saito^{4

5

6}, H Ito⁷, K Inamura^{1

8}

¹ Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), Tokyo, 135-8550, Japan.
² Department of Human Pathology, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Tokyo, 113-8519, Japan.
³ Division of Pathology, The Cancer Institute, JFCR, Tokyo, 135-8550, Japan.
⁴ Department of Medical Oncology, Cancer Institute Hospital, JFCR, Tokyo, 135-8550, Japan.
⁵ Department of Clinical Chemotherapy, Cancer Chemotherapy Center, JFCR, Tokyo, 135-8550, Japan.
⁶ Graduate School of Engineering, Chiba Institute of Technology, Chiba, 275-0016, Japan.
⁷ Division of Hepatobiliary-Pancreatic Surgery, Cancer Institute Hospital, JFCR, Tokyo, 135-8550, Japan.
⁸ Department of Pathology, Jichi Medical University, Tochigi, 329-0498, Japan.

No abstract available

Grants and funding